if you have cystinuria
TRPV1, transient receptor potential vanilloid 1
This week: tirzepatide vs semaglutide results from 20,000+ patients, new data on the start-and-stop journey, groundbreaking research on GLP-1s rewiring impulsive behaviour, and why your step count matters more than you think.Plus Father's Day waffle, World Cup chat, and the first ever fully integrated sponsor on the channel.This week's stories: Tirzepatide vs Semaglutide: Real-world data from 20,000+ patients The Start & Stop trend 58% restart within 2 years GLP-1s and impulsive behaviour: the brain rewiring study Physical activity drop & the muscle loss warning Check out all the update videos on YouTube: YouTube Weekly Videos *The episodes in this series are recorded as YouTube videos
Hussain A, Tabrez E, Peela J, Honnavar PD, Tabrez SSM
The first step in the pre-operative care of a patient on GLP-1RAs should involve an assessment of the risk of aspiration, taking into account factors that may increase this risk, including the escalation phase of GLP-1RA dosing or a high-dose protocol, the presence of gastrointestinal symptoms of delayed gastric emptying (e.g
Common side effects include temporary redness, swelling, and bruising at the injection site, usually subsiding within a few days